These findings establish NRG4 as a metastasis suppressor in obesity-associated breast cancer by inhibiting the ERBB4-YAP1 pathway and down-regulating matrix metalloproteinases. This evidence concerns the gene ERBB4 and obesity due to melanocortin 4 receptor deficiency.